Human insulin as both antigen and protector in type 1 diabetes
European Journal of Immunology · 2024
DOI: 10.1002/eji.202350949 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Nitin P Amdare und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Mice, Inbred NOD, Mice, Transgenic, Insulin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, Diabetes Research Center of the Albert Einstein College of Medicine; and NIDDK-supported Human Islet Research Network.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes (T1D) is characterized by T‐cell responses to islet antigens. Investigations in humans and the nonobese diabetic (NOD) mouse model of T1D have revealed that T‐cell reactivity to insulin plays a central role in the autoimmune response. As there is no convenient NOD‐based model to study human insulin (hIns) or its T‐cell epitopes in the context of spontaneous T1D, we developed a NOD mouse strain transgenically expressing hIns in islets under the control of the human regulatory region. Female NOD. hIns mice developed T1D at approximately the same rate and overall incidence as NOD mice. Islet‐infiltrating T cells from NOD. hIns mice recognized hIns peptides; both CD8 and CD4 T‐cell epitopes were identified. We also demonstrate that islet‐infiltrating T cells from HLA‐transgenic NOD. hIns mice can be used to identify potentially patient‐relevant hIns T‐cell epitopes. Besides serving as an antigen, hIns was expressed in the thymus of NOD. hIns mice and could serve as a protector against T1D under certain circumstances, as previously suggested by genetic studies in humans. NOD. hIns mice and related strains facilitate human‐relevant epitope discovery efforts and the investigation of fundamental questions that cannot be readily addressed in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
- The Jackson Laboratory, Bar Harbor, Maine, USA.
- Program in Molecular Medicine, Diabetes Center of Excellence, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
- Department of Medicine (Division of Endocrinology and Diabetes), Albert Einstein College of Medicine, Bronx, New York, USA.
- Einstein-Mount Sinai Diabetes Research Center, Albert Einstein College of Medicine, Bronx, New York, USA.
- The Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, New York, USA.
ORCID-Profile: Teresa P DiLorenzo
Förderung
- NIDDK NIH HHS
- NIH HHS
- Diabetes Research Center of the Albert Einstein College of Medicine; and NIDDK-supported Human Islet Research Network
- NIAID NIH HHS
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Amdare, N. P., Shultz, L. D., Greiner, D. L., & DiLorenzo, T. P. (2024). Human insulin as both antigen and protector in type 1 diabetes. European Journal of Immunology. https://doi.org/10.1002/eji.202350949
Vancouver
Amdare NP, Shultz LD, Greiner DL, DiLorenzo TP. Human insulin as both antigen and protector in type 1 diabetes. European Journal of Immunology. 2024. doi:10.1002/eji.202350949
BibTeX
@article{Amdare2024,
author = {Amdare, Nitin P and Shultz, Leonard D and Greiner, Dale L and DiLorenzo, Teresa P},
title = {Human insulin as both antigen and protector in type 1 diabetes},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202350949}
}
EUVIMED